MED News 33.60 09/02/2014 05:17:37 Medifast Inc (MED)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medifast Inc (MED) 33.60 $MED

Medifast (MED) is Overbought: Is A Drop Coming? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 10:13AM CDT
Medifast (MED) is Overbought: Is A Drop Coming?

Medifast Adopts One-Year Stockholder Rights Plan
PR Newswire - Thu Aug 28, 3:45PM CDT
Medifast (NYSE: MED) today announced that its Board of Directors has unanimously adopted a one-year stockholder rights plan (the "Rights Plan" and declared a dividend of one right for each outstanding share of Medifast common stock. The Rights Plan expires on August 28, 2015, and the Board of Directors may terminate the Rights Plan at any time if it no longer believes that the Rights Plan is in the best interests of the Company and its stockholders.

NYSE stocks posting largest percentage increases
AP - Tue Aug 26, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:

Medifast Down 11.0% Since SmarTrend Downtrend Call (MED)
Comtex SmarTrend(R) - Mon Aug 18, 10:50AM CDT
SmarTrend identified a Downtrend for Medifast (NYSE:MED) on June 27th, 2014 at $30.84. In approximately 2 months, Medifast has returned 10.97% as of today's recent price of $27.46.

Bear of the Day: Medifast (MED) - Bear of the Day
David Bartosiak - ZACKS - Mon Aug 18, 2:22AM CDT
Bear of the Day: Medifast (MED) - Bear of the Day

Take Shape For Life Announces Winners of National Stop.Challenge.Choose. 12-Week Health Transformation
PR Newswire - Thu Aug 14, 4:19PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss products and programs announced the winners of Take Shape For Life's inaugural Stop.Challenge.Choose. 12-Week Health Transformation. The challenge kicked off January 1, 2014, with the goal of encouraging participants to lead healthier lifestyles. Ten winners were selected out of more than 20,000 participants.

MEDIFAST SHAREHOLDER ALERT - Medifast Inc.: The Law Offices of Vincent Wong Launch an Investigation into Medifast Inc. - MED
Business Wire - Tue Aug 12, 3:59PM CDT
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Medifast Inc. (NYSE:MED) in connection with possible claims of breaches of fiduciary duty by the Board of Directors.

Shares of MED Down 14.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Aug 11, 9:43AM CDT
SmarTrend identified a Downtrend for Medifast (NYSE:MED) on June 27th, 2014 at $30.84. In approximately 2 month, Medifast has returned 14.85% as of today's recent price of $26.26.

Weakness Seen in Medifast (MED): Stock Tumbles 9.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 11, 7:58AM CDT
Medifast (MED) fell nearly 10% in the last trading session amid huge volumes, continuing its recent trend, as the stock is now down over 15% in the past one-month time frame.

NYSE stocks posting largest volume increases
AP - Fri Aug 08, 5:06PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:

Medifast, Inc. Announces Second Quarter 2014 Financial Results
PR Newswire - Thu Aug 07, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss products and programs, today reported financial results for the second quarter ended June 30, 2014.

Medifast Announces $100,000 Grant to The V Foundation for Cancer Research
PR Newswire - Wed Aug 06, 7:00AM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss products and programs announced today a $100,000 grant to The V Foundation for Cancer Research, one of the nation's leading cancer research funding organizations.

INVESTOR ALERT - Medifast Inc.: The Law Offices of Vincent Wong Launch an Investigation into Medifast Inc.
Business Wire - Thu Jul 31, 12:56PM CDT
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Medifast Inc. (NYSE: MED) in connection with possible claims of breaches of fiduciary duty by the Board of Directors.

Medifast, Inc. to Participate in the Canaccord Genuity 34th Annual Growth Conference
PR Newswire - Thu Jul 31, 7:00AM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, weight-loss products and programs, announced today that Michael C. MacDonald, Executive Chairman and Chief Executive Officer, and Timothy Robinson, Chief Financial Officer, will present at the Canaccord Genuity 34th Annual Growth Conference on Thursday, August 14, 2014 in Boston, MA.

Take Shape For Life Launches Habits of Healthy Sleep Set
PR Newswire - Wed Jul 30, 7:00AM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss products and programs, is proud to announce a new line of products available in its Take Shape For Life division. The new Habits of Healthy Sleep Set will feature a Far-Infrared Blanket, Melatonin, Restfulmind(TM) Herbal Sleep Tea, Chilltime(TM) Theanine Supplement Gum, and a sleep mask and ear plugs set.

Medifast Adds New Snacks to Product Line
PR Newswire - Tue Jul 22, 3:30PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, is excited to announce four new snacks to complement its line of weight management products. The new additions feature two chips and two popcorn choices: Sea Salt & Olive Oil Veggie Chips, Spicy Black Bean Veggie Chips, Sea Salt Popcorn and Cheddar & Sour Cream Popcorn.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 206

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 376

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 177

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 243

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 407

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 168

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 338

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading

Top 5 Most Recently Viewed Articles

Viatris Launches Cash Tender Offers for Outstanding Notes

Updated Category News Views 56

Viatris Launches Cash Tender Offers for Outstanding Notes Viatris Inc. (NASDAQ: VTRS), a leading player in the global healthcare sector, has initiated tender offers to acquire certain outstanding notes. This move is designed to strengthen its financial framework and enhance returns for its shareholders. Notably, the offers include various senior notes that were originally...

Continue Reading
Coke Florida Launches Joyful Holiday Caravan Across Florida

Updated Category News Views 239

Coke Florida Kicks Off Holiday Spirit with Caravan Tour Coca-Cola Beverages Florida, LLC (Coke Florida) is thrilled to share that its beloved annual "Holiday Caravan" is set to return. This event, which has become an essential part of the holiday season, features the iconic Coca-Cola red delivery truck decked out in festive cheer. Families will enjoy complimentary samples...

Continue Reading
Nexxen to Join RBC Conference, Share Insights on Technology

Updated Category News Views 68

Nexxen's Upcoming Participation at RBC Global Conference Nexxen International Ltd. (AIM/NASDAQ: NEXN), a leading global advertising technology platform, is geared up to take part in a significant event, the RBC Global Technology, Internet, Media and Telecommunications Conference. This event provides a stellar opportunity for companies to connect with investors and share...

Continue Reading
GayVeterans.us Obtains 501(c)(3) Status to Broaden Support

Updated Category News Views 125

GayVeterans.us Achieves 501(c)(3) Tax Exempt Status GayVeteransUS-Inc. has recently been granted 501(c)(3) tax-exempt status, marking a significant milestone for the organization. This designation enables supporters to make tax-deductible contributions, strengthening the community's ability to provide enhanced resources and support. The dedication of veteran volunteers...

Continue Reading
Virbac Expands Portfolio with Acquisition of Felanorm Solution

Updated Category News Views 130

Virbac Enhances Its Offerings with Felanorm Acquisition Virbac has announced a significant acquisition that marks a pivotal moment in its commitment to improving the health and quality of life for senior cats. This globally recognized drug is aimed at treating feline hyperthyroidism, a condition that is becoming increasingly common in older cats. Understanding Feline...

Continue Reading